166 related articles for article (PubMed ID: 2521277)
1. Immunologic assessment of a cluster of asymptomatic HTLV-I-infected individuals in New Orleans.
deShazo RD; Chadha N; Morgan JE; Shorty VJ; Rangan SR; Kalyanaraman VS; Hyslop N; Chapman Y; O'Dea S
Am J Med; 1989 Jan; 86(1):65-70. PubMed ID: 2521277
[TBL] [Abstract][Full Text] [Related]
2. Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone.
Klimas NG; Blaney NT; Morgan RO; Chitwood D; Milles K; Lee H; Fletcher MA
Am J Med; 1991 Feb; 90(2):163-70. PubMed ID: 1671730
[TBL] [Abstract][Full Text] [Related]
3. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
Lal RB; Rudolph DL; Schmid DS; Lairmore MD
Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases.
Morimoto C; Romain PL; Fox DA; Anderson P; DiMaggio M; Levine H; Schlossman SF
Am J Med; 1988 May; 84(5):817-25. PubMed ID: 2966579
[TBL] [Abstract][Full Text] [Related]
5. Effects of retroviral infections on immune function in African-American intravenous drug users.
Klimas NG; Page JB; Patarca R; Chitwood D; Morgan R; Fletcher MA
AIDS; 1993 Mar; 7(3):331-5. PubMed ID: 8471194
[TBL] [Abstract][Full Text] [Related]
6. A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users.
Rosenblatt JD; Plaeger-Marshall S; Giorgi JV; Swanson P; Chen IS; Chin E; Wang HJ; Canavaggio M; Hausner MA; Black AC
Blood; 1990 Jul; 76(2):409-17. PubMed ID: 1973360
[TBL] [Abstract][Full Text] [Related]
7. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.
Itoyama Y; Kira J; Fujii N; Goto I; Yamamoto N
Ann Neurol; 1989 Aug; 26(2):257-62. PubMed ID: 2528320
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study Group.
Fletcher MA; Gjerset GF; Hassett J; Donegan E; Parker JW; Mosley JW
J Acquir Immune Defic Syndr (1988); 1991; 4(6):628-32. PubMed ID: 1673714
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
[TBL] [Abstract][Full Text] [Related]
10. T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection.
Morgan JE; Daul CB; de Shazo RD; Andes WA; Hyslop NH
J Clin Immunol; 1989 Mar; 9(2):97-102. PubMed ID: 2523902
[TBL] [Abstract][Full Text] [Related]
11. Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study.
Halder RM; Walters CS; Johnson BA; Chakrabarti SG; Kenney JA
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):733-7. PubMed ID: 2940268
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
13. Predominance of T cells that express CD45R in the CD4+ helper/inducer lymphocyte subset of neonates.
Bradley LM; Bradley JS; Ching DL; Shiigi SM
Clin Immunol Immunopathol; 1989 Jun; 51(3):426-35. PubMed ID: 2524299
[TBL] [Abstract][Full Text] [Related]
14. Decrease in phenotypically defined T helper inducer cells (T4+4B4+) and increase in T suppressor effector cells (T8+2H4+) in stable renal allograft recipients.
Ramos EL; Turka LA; Leggat JE; Wood IG; Milford EL; Carpenter CB
Transplantation; 1989 Mar; 47(3):465-71. PubMed ID: 2522253
[TBL] [Abstract][Full Text] [Related]
15. Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?
Gudo ES; Bhatt NB; Bila DR; Abreu CM; Tanuri A; Savino W; Silva-Barbosa SD; Jani IV
BMC Infect Dis; 2009 Dec; 9():211. PubMed ID: 20028500
[TBL] [Abstract][Full Text] [Related]
16. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
17. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic analysis of lamina propria lymphocytes. Predominance of helper-inducer and cytolytic T-cell phenotypes and deficiency of suppressor-inducer phenotypes in Crohn's disease and control patients.
James SP; Fiocchi C; Graeff AS; Strober W
Gastroenterology; 1986 Dec; 91(6):1483-9. PubMed ID: 2945749
[TBL] [Abstract][Full Text] [Related]
19. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects.
Vuillier F; Lapresle C; Dighiero G
Clin Exp Immunol; 1988 Jan; 71(1):8-12. PubMed ID: 2964959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
